SCHEMBL25464108

SCHEMBL25464108

CC(C)(C(=O)NC1CC1)c1cc(F)ccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 2/20 0.47
▸ TAS1R1 Q7RTX1 2/20 0.47
▸ TAS1R2 Q8TE23 2/20 0.47
▸ HPGD P15428 1/20 0.44
▸ RAB9A P51151 3/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ SSTR4 P31391 3/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ EPHX2 P34913 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ LMNA P02545 1/20 0.38
▸ ACKR3 P25106 1/20 0.38
▸ DPP4 P27487 1/20 0.37
▸ PSEN1 P49768 1/20 0.37
▸ PSEN2 P49810 1/20 0.37
▸ APH1B Q8WW43 1/20 0.37
▸ NCSTN Q92542 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25460802 0.80 CES2 (0.40) HPGDRAB9ANPC1MEN1ALDH1A1
SCHEMBL25464213 0.78 NPC1 (0.49) HPGDRAB9ANPC1SSTR4MEN1
SCHEMBL25464167 0.78 NPC1 (0.43) TAS1R3TAS1R1TAS1R2HPGDRAB9A
SCHEMBL25464188 0.77 KMT2A (0.47) HPGDRAB9ANPC1SSTR4MEN1
SCHEMBL25464109 0.77 L3MBTL1 (0.44) TAS1R3TAS1R1TAS1R2HPGDRAB9A
SCHEMBL25262844 0.74 CES2 (0.44) MEN1KMT2A
SCHEMBL25464172 0.74 SSTR4 (0.44) TAS1R3TAS1R1TAS1R2HPGDRAB9A
SCHEMBL25464079 0.71 GRM5 (0.50) RAB9ANPC1SSTR4MEN1KMT2A
SCHEMBL17030739 0.71 TAS1R3 (0.71) TAS1R3TAS1R1TAS1R2HPGDRAB9A
SCHEMBL182166 0.70 SIGMAR1 (0.57) POLBMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR TAS1R3 690/4885TAS1R1 609/4885TAS1R2 643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback